September 7, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX ProLeft Atrial Appendage Closure (LAAC) ...
Left Atrial Appendage (LAA) Occluders
This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.
-
-
July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions for Use (IFU) do not adequately address precautions to take when treating patients ...
-
July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device. Air embolism ...
-
May 22, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and cardiac rhythm management therapies, and the WATCHMAN FLX Left Atrial Appendage ...
September 7, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval ...
September 07, 2023
July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...
July 27, 2023
July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to ...
July 26, 2023
May 25, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...
May 25, 2023
May 22, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...
May 22, 2023
April 18, 2023 — Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting ...
April 18, 2023
March 28, 2023 — The Society for Cardiovascular Angiography and Interventions (SCAI) and the Heart Rhythm Society (HRS) ...
March 28, 2023
February 27, 2023 — Conformal Medical, Inc. announced today the results from the CONFORMAL Early Feasibility Study (EFS) ...
February 27, 2023
December 22, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac ...
December 22, 2022
Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World ...
December 20, 2022
September 12, 2022 — Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval to ...
September 12, 2022
June 27, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias ...
June 28, 2022
May 25, 2022 — ŌNŌCOR LLC, a leader in endovascular safety technology, today announced it has received 510(k) U.S. Food ...
May 25, 2022
April 12, 2022 – Patients who had leakage to the left atrial appendage due to incomplete device sealing after left ...
April 12, 2022
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
February 28, 2022 – Boston Scientific Corporation has announced positive results from a new analysis assessing real ...
February 28, 2022© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now